Clinical Trial Update: A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Orforglipron (LY3502970) in adolescent participants with obesity or overweight with related comorbidities is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Orforglipron (orforglipron)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 3 | Status: RECRUITING